July 25, 2014 9:41 AM ET

Pharmaceuticals

Company Overview of Shilpa Medicare Limited

Company Overview

Shilpa Medicare Limited engages in the manufacture and sale of bulk drugs and intermediates in India. It offers oncology products, active pharmaceutical ingredients, fine chemicals, herbal products, and specialty chemical products. The company also exports its products to the United States, Canada, Australia, and Japan; European countries, such as Germany, Switzerland, the Netherlands, Belgium, Spain, Greece, Cyprus, Italy, the United Kingdom, etc.; South American countries, including Mexico, Brazil, Columbia, etc.; African countries comprising Kenya, Nigeria, West Indies, etc.; and Asian countries consisting of Singapore, Taiwan, China, Malaysia, and Thailand. Shilpa Medicare Limited was fo...

10/80, Rajendra Gunj

1st Floor

Raichur,  584102

India

Founded in 1987

Phone:

91 85 3223 5704

Fax:

91 85 3223 5876

Key Executives for Shilpa Medicare Limited

Shilpa Medicare Limited does not have any Key Executives recorded.

Shilpa Medicare Limited Key Developments

Shilpa Medicare Limited Reports Consolidated and Standalone Earnings Results for the Fourth Quarter and Year Ended March 31, 2014

Shilpa Medicare Limited reported consolidated and standalone earnings results for the fourth quarter and year ended March 31, 2014. For the quarter, standalone total income from operations was INR 1,563.767 million, profit from operations before other income, finance costs and exceptional items was INR 299.628 million, profit from ordinary activates before tax was INR 306.615 million net profit was INR 233.055 million or INR 6.05 per diluted after extraordinary items (not annualized) against total income from operations was INR 868.750 million, profit from operations before other income, finance costs and exceptional items was INR 145.211 million, profit from ordinary activates before tax of INR 155.288 million net profit was INR 131.235 million or INR 3.38 per diluted after extraordinary items (not annualized) a year ago. For the year, standalone total income from operations was INR 1,674.452 million, profit from operations before other income, finance costs and exceptional items was INR 295.032 million, profit from ordinary activates before tax was INR 311.775 million net profit was INR 248.778 million or INR 6.41 per diluted after extraordinary items (not annualized) against total income from operations was INR 985.240 million, profit from operations before other income, finance costs and exceptional items was INR 136.427 million, profit from ordinary activates before tax of INR 149.626 million net profit was INR 126.546 million or INR 3.22 per diluted after extraordinary items (not annualized) a year ago. For the quarter, consolidated total income from operations was INR 5,276.681 million, profit from operations before other income, finance costs and exceptional items was INR 966.260 million, profit from ordinary activates before tax was INR 1,020.809 million net profit was INR 808.568 million or INR 20.97 per diluted after extraordinary items (not annualized) against total income from operations was INR 3,281.959 million, profit from operations before other income, finance costs and exceptional items was INR 520.680 million, profit from ordinary activates before tax of INR 557.150 million net profit was INR 751.494 million or INR 11.89 per diluted after extraordinary items (not annualized) a year ago. For the year, consolidated total income from operations was INR 5,713.762 million, profit from operations before other income, finance costs and exceptional items was INR 928.080 million, profit from ordinary activates before tax was INR 983.543 million net profit was INR 751.494 million or INR 18.88 per diluted after extraordinary items (not annualized) against total income from operations was INR 3,713.234 million, profit from operations before other income, finance costs and exceptional items was INR 535.279 million, profit from ordinary activates before tax of INR 571.024 million net profit was INR 474.679 million or INR 12.25 per diluted after extraordinary items (not annualized) a year ago.

Shilpa Medicare Limited Recommends Dividend for the Financial Year of 2013 to 2014

The Board of directors of Shilpa Medicare Limited recommended a dividend of INR 1.00 per share(i.e. 50%) of face value of INR 2 for the financial year of 2013 to 2014, subject to approval of shareholders in ensuring annual general meeting.

Shilpa Medicare Limited to Report Fiscal Year 2014 Results on May 29, 2014

Shilpa Medicare Limited announced that they will report fiscal year 2014 results on May 29, 2014

Recent Private Companies Transactions

Type
Date
Target
Private Placement
April 11, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Shilpa Medicare Limited, please visit www.vbshilpa.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.